|
DYRK1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.98190000364218E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.6535999952948E-08 |
| Normal-vs-Stage2 |
1.539440E-03 |
| Normal-vs-Stage3 |
1.63314999999109E-05 |
| Normal-vs-Stage4 |
4.396100E-03 |
| Stage1-vs-Stage2 |
9.661800E-01 |
| Stage1-vs-Stage3 |
6.213200E-01 |
| Stage1-vs-Stage4 |
5.064800E-01 |
| Stage2-vs-Stage3 |
7.111200E-01 |
| Stage2-vs-Stage4 |
5.466200E-01 |
| Stage3-vs-Stage4 |
7.013800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.37369959430612E-10 |
| Normal-vs-AfricanAmerican |
1.029270E-04 |
| Normal-vs-Asian |
1.397110E-03 |
| Caucasian-vs-AfricanAmerican |
2.100000E-01 |
| Caucasian-vs-Asian |
9.840600E-01 |
| AfricanAmerican-vs-Asian |
6.728600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07749997813045E-09 |
| Normal-vs-Female |
2.584700E-04 |
| Male-vs-Female |
1.198210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.52069999995275E-06 |
| Normal-vs-Extreme_Weight |
4.03359999845421E-08 |
| Normal-vs-Obese |
8.32780000000755E-05 |
| Normal-vs-Extreme_Obese |
3.480300E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.952800E-01 |
| Normal_Weight-vs-Obese |
2.678800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.978000E-01 |
| Extreme_Weight-vs-Obese |
1.394980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.347800E-01 |
| Obese-vs-Extreme_Obese |
1.814550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.017360E-04 |
| Normal-vs-Age(41-60Yrs) |
1.82923999999529E-05 |
| Normal-vs-Age(61-80Yrs) |
9.68769953146875E-10 |
| Normal-vs-Age(81-100Yrs) |
3.02949999975155E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.311800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.749400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.628030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.609600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.242100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.501000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.06839999958197E-07 |
| Normal-VS-Type2 PRCC |
2.31640262526867E-11 |
| Normal-VS-KIRP CIMP |
8.05470000000419E-05 |
| Normal-VS-Unclassified PRCC |
1.449220E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.678400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.642000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.367000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.933400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.050820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.395000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00899955057798E-10 |
| Normal-vs-N1 |
2.582000E-03 |
| Normal-vs-N2 |
2.038900E-04 |
| N0-vs-N1 |
7.589700E-02 |
| N0-vs-N2 |
6.739400E-01 |
| N1-vs-N2 |
3.178600E-01 |
|
|
